Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sarosiek

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bone Marrow Transplantation|July 20, 2007
Biochemical indices for the assessment of nutritional status during hematopoietic stem cell transplantation: are they worth using? A single center experienceP Rzepecki, J Barzal, T Sarosiek, et al.
Cancer Treatment Reviews|September 28, 2000
Antisense therapy in cancerW Pawlak, J Zolnierek, T Sarosiek, et al.
Neoplasma|May 6, 2005
Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experienceP Rzepecki, J Zolnierek, T Sarosiek, et al.
Transplantation Proceedings|November 21, 2007
Which parameters of nutritional status should we choose for nutritional assessment during hematopoietic stem cell transplantation?P Rzepecki, J Barzal, T Sarosiek, et al.
Neoplasma|August 11, 2007
How can we help patients with refractory chronic graft versus host disease- single centre experienceP Rzepecki, J Barzal, T Sarosiek, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 30, 2007
Nutritional assessment during allogeneic hematopoietic stem cell transplantation: single centre experienceR Rzepecki, J Barzal, T Sarosiek, et al.
Journal of Chemotherapy (Florence, Italy)|March 18, 2008
Prevention of cytomegalovirus reactivaction after allogenic hematopoietic stem cell transplantation with valganciclovir: single center experienceP Rzepecki, J Barzal, T Sarosiek, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 6, 2007
Multimodality treatment of germ cell cancer patients who had progression or relapse after high dose chemotherapy and autologous bone marrow transplantationT Sarosiek, P Rzepecki, P Langiewicz, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 11, 2007
Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experienceP Rzepecki, T Sarosiek, J Barzal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2014
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapyM Aapro, H Rugo, G Rossi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bone Marrow Transplantation|July 20, 2007
Biochemical indices for the assessment of nutritional status during hematopoietic stem cell transplantation: are they worth using? A single center experienceP Rzepecki, J Barzal, T Sarosiek, et al.
Cancer Treatment Reviews|September 28, 2000
Antisense therapy in cancerW Pawlak, J Zolnierek, T Sarosiek, et al.
Neoplasma|May 6, 2005
Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experienceP Rzepecki, J Zolnierek, T Sarosiek, et al.
Transplantation Proceedings|November 21, 2007
Which parameters of nutritional status should we choose for nutritional assessment during hematopoietic stem cell transplantation?P Rzepecki, J Barzal, T Sarosiek, et al.
Neoplasma|August 11, 2007
How can we help patients with refractory chronic graft versus host disease- single centre experienceP Rzepecki, J Barzal, T Sarosiek, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 30, 2007
Nutritional assessment during allogeneic hematopoietic stem cell transplantation: single centre experienceR Rzepecki, J Barzal, T Sarosiek, et al.
Journal of Chemotherapy (Florence, Italy)|March 18, 2008
Prevention of cytomegalovirus reactivaction after allogenic hematopoietic stem cell transplantation with valganciclovir: single center experienceP Rzepecki, J Barzal, T Sarosiek, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 6, 2007
Multimodality treatment of germ cell cancer patients who had progression or relapse after high dose chemotherapy and autologous bone marrow transplantationT Sarosiek, P Rzepecki, P Langiewicz, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 11, 2007
Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experienceP Rzepecki, T Sarosiek, J Barzal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2014
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapyM Aapro, H Rugo, G Rossi, et al.
Pageof 2